DAPTA

SKU: orb1299650

Description

DAPTA (Adaptavir) is a small molecule CCR5 antagonist with demonstrated anti-HIV activity. It is a research tool for studying viral entry mechanisms and has been utilized in both in vitro assays and in vivo animal models of HIV infection.

Research Area

Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry

Key Properties

• Target: CCR,HIV Protease
• CAS Number: 106362-34-9
• MW: 856.88
• Purity: >99.99% (May vary between batches)
• Formula: C₃₅H₅₆N₁₀O₁₅
• SMILES: C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

HIV Protease, HIV, HIVProtease, CCR, CCR5, Adaptavir, CC chemokine receptor, D-Ala-peptide T-amide, DAPTA

Compound Identifiers

PubChem CID

184644